Compounding Pharmacies Market

Global Compounding Pharmacies Market Size, Trends & Analysis - Forecasts to 2028 By Therapeutic Area (Hormone Replacement Therapy, Pain Management, Specialty Drugs, Dermatology, Nutritional Supplements, and Others), By Age Cohort (Paediatric, Adult, and Geriatric), By Compounding Type (Pharmaceutical Ingredient Alteration (PIA), Currently Unavailable Pharmaceutical Manufacturing (CUPM), Pharmaceutical Dosage Alteration (PDA), and Others), By Sterility (Sterile and Non-sterile), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis

Category Healthcare
Format
  • ms word
  • ms excel
  • ms ppt
  • pdf
This report was recently updated on May 12 2024 with the latest and most recent market numbers

Global Compounding Pharmacies Market Size

The global Compounding Pharmacies market is projected to grow at a CAGR of 6% from 2023 to 2028.

The market is experiencing growth due to factors like the rising aging population worldwide and a global increase in awareness about compounding pharmacies and demand for personalized medications. For example, according to World Health Organization (October 2021), it was projected that one in every six people worldwide would be aged 60 or older by 2030. This aging demographic is more susceptible to multiple chronic conditions like cardiovascular diseases, cancer, multiple sclerosis, and urinary incontinence, necessitating personalized treatments. Consequently, there is an increase in demand for compounding pharmacies to address these chronic diseases in the elderly population, thereby propelling market growth during the forecast period.

Shortages of commercially available medications, particularly for chronic conditions, have increased the demand for compounded medications as an alternative source of essential drugs. According to the Medicine Shortage Survey 2022 by the Pharmaceutical Group of the European Union (PGEU), all 29 surveyed European countries reported medication shortages within community pharmacies. The majority of these shortages were related to cardiovascular medications. Pharmaceutical compounding is frequently seen as the solution to mitigate these medication shortages and bridge the gaps caused by the unavailability of certain drugs.

A rising preference for personalized medications, increased product launches by key compounding drug companies, expanding research efforts in the field, and the challenge of timely access to standard medications are factors expected to boost market growth during the foreseeable future. For example, in February 2023, a leading U.S. eye care pharmaceutical company, Harrow, introduced its patent-pending advanced compounded Atropine formulations through ImprimisRx.

Restriction on manufacturing complex compounds are expected to hinder market expansion due to heightened restrictions on the production of complicated mixtures.

global compounding pharmacies market

Global Compounding Pharmacies Market: By Therapeutic Area

Pain management segment is expected to hold the largest share of the market. This can be attributed to the growing incidence of chronic pain and the side effects associated with frequently used pain management medications. Compounded pain management medications offer various advantages, such as bypassing the gastrointestinal (GI) system for patients experiencing GI-related side effects and consolidating multiple medications into a single dose.

Nutritional supplements is expected to be the fastest-growing segment in the market from 2023-2028. This can be attributed to the increasing desire for personalized beauty and anti-aging solutions. Consequently, numerous companies are responding to this demand by providing a variety of compounded nutraceutical products. For example, Medisca Inc. offers a comprehensive selection of over 100 top-quality compounded nutraceutical products, rigorously tested for heavy metals. These offerings include prenatal multivitamins, minerals, antioxidants, and various other supplements.

Global Compounding Pharmacies Market: By Age Cohort

Paediatric is anticipated to be the fastest-growing segment in the market from 2023-2028. Customized medications are frequently used for children due to their smaller stature, preference for specific flavours, limited dosage options, and challenges associated with swallowing solid forms of medication. These tailored medications enhance medication adherence and simplify the process of children taking their prescribed drugs. Consequently, numerous companies are introducing personalized compounded medications tailored to this age group. For instance, in March 2021, Children's Hospital Colorado, in collaboration with STAQ Pharma, introduced a line of compounded medications specifically designed for paediatric patients.

Adult segment is expected to hold the largest share of the market. Adult patients often require customized medications because of factors like sensitivities to particular ingredients and the need for specific dosage strengths. Compounding pharmacies are well-equipped to meet these demands by producing personalized medications in various forms like creams, capsules, or gels.

Global Compounding Pharmacies Market: By Sterility

The sterility is anticipated to be the fastest-growing segment in the market during 2023-2028. The growth of the sterile segment can be attributed to the increasing demand for sterile-compounded medications across various healthcare settings. Additionally, advancements in medical treatments according to patient needs are contributing to the segment's growth. For example, in October 2019, the National Association of Boards of Pharmacy secured funding from the United States Food and Drug Administration (FDA) to establish a data-sharing system with the goal of improving oversight and regulation of sterile compounding pharmacies.

The non-sterility segment holds the largest share of the market. Non sterile compounding is primarily utilized to produce oral and topical preparations, encompassing capsules, solutions, suspensions, ointments, creams, and suppositories. Oral medication is the most prevalent method of administering drugs due to its benefits, including the convenience it offers to patients, their preference for this route, cost-effectiveness, and the ease of producing oral dosage forms on a large scale. According to the study conducted by National library or Medicine in 2021 on the “Advances in Oral Drug Delivery”, approximately 84% of the top-selling pharmaceutical products are taken orally, contributing to a market worth USD 35 billion.

Global Compounding Pharmacies Market: By Compounding Type

The pharmaceutical dosage alteration (PDA) is anticipated to be the fastest-growing segment in the market from 2023-2028 due to its ability to tailor medication dosages to individual patient needs and ensuring optimal therapeutic outcomes. This customization addresses specific requirements, including allergies, sensitivities, and dosage forms not met by commercially available drugs.

The pharmaceutical ingredient alteration (PIA) segment holds the largest share of the market. Pharmaceutical Ingredient Alteration (PIA) involves the composition or concentration of active ingredients in medications, commonly performed to customize it for specific individual patients. According to a report titled "The Role of Pharmaceutical Compounding in Promoting Medication Adherence" from 2022, it is estimated that compounded medicines make up approximately 1% to 3% of pharmaceutical prescriptions, and their utilization is on the rise.

asia pacific compounding pharmacies market

Global Compounding Pharmacies Market: By Region

Regionally, North America is expected to be the largest region in the global market. The primary reasons boosting the market growth in this region include increasing presence of various compounding pharmacies and shortages of specific medications. Data from the American Pharmacists Association in October 2021 revealed that the U.S. had more than 56,000 community pharmacies, with 7,500 of them providing advanced compounding services.

Asia Pacific is predicted to witness rapid growth during the forecast period. The growth is being propelled by factors including the growing aging populations, the increasing prevalence of chronic illnesses, the expansion of healthcare facilities, and a rising awareness demand for alternative treatments. As per the Asian Development Bank, projections indicate that by 2050, one out of every four individuals in Asia and the Pacific will be aged 60 or older. During the period from 2010 to 2050, the elderly population (aged over 60) in the region is anticipated to triple, reaching nearly 1.3 billion people.

Global Compounding Pharmacies Market Share and Competitor Analysis

Walgreen Co., JL Diekman and AQ Touchard, Fagron, Albertsons Companies, The London Specialist Pharmacy Ltd, Galenic Laboratories Limited, Aurora Compounding, MEDS Pharmacy, Apollo Clinical Pharmacy, and Formul8, among others, are some of the key players operating in the global compounding pharmacies market.

Please note: This is not an exhaustive list of companies profiled in the report.

Global Compounding Pharmacies Market Recent Development

Industry players are prioritizing innovation and strategic business initiatives to remain competitive. In July 2022, Fagron expanded its sterile compounding presence in the U.S. by acquiring a 503B outsourcing facility in Boston from Fresenius Kabi. These moves signify the industry's commitment to development and expansion.

1          STRATEGIC INSIGHTS ON NEW REVENUE POCKETS

1.1    Strategic Opportunity & Attractiveness Analysis

1.1.1        Hot Revenue Pockets

1.1.2        Market Attractiveness Score

1.1.3        Revenue Impacting Opportunity

1.1.4        High Growing Region/Country

1.1.5        Competitor Analysis

1.1.6        Consumer Analysis

1.2    Global Market Estimates' View

1.3    Strategic Insights across Business Functions

1.3.1        For Chief Executive Officers

1.3.2        For Chief Marketing Officers

1.3.3        For Chief Strategy Officers

1.4    Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into

2          TECHNOLOGICAL TRENDS

2.1   Technological Adoption Rate

2.2   Current Trend Impact Analysis

2.3   Future Trend Impact Analysis

3          GLOBAL MARKET OUTLOOK

3.1   Market Pyramid Analysis

3.1.1        Introduction

3.1.2           Adjacent Market Opportunities

3.1.3           Ancillary Market Opportunities

3.2   Demand Side Analysis

3.2.1           Market Drivers: Impact Analysis

3.2.2           Market Restraints: Impact Analysis

3.2.3           Market Opportunities: Impact Analysis

3.2.4           Market Challenges: Impact Analysis

3.3   Supply Side Analysis

3.3.1           Porter’s Five Forces Analysis

3.3.1.1 Threat of New Entrants

3.3.1.2 Threat of New Substitutes

3.3.1.3 Bargaining Power of Suppliers

3.3.1.4 Bargaining Power of Buyers

3.3.1.5 Intensity of Competitive Rivalry

3.3.2           SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)

3.3.2.1 Political Landscape

3.3.2.2 Economic Landscape

3.3.2.3 Social Landscape

3.3.2.4 Technology Landscape

3.3.3        Value Chain Analysis

3.3.4        Trend Analysis

3.3.5        Gap Analysis

3.3.6        Cost Analysis

4          GLOBAL COMPOUNDING PHARMACIES MARKET, BY THERAPEUTIC AREA

4.1   Introduction

4.2   Compounding Pharmacies Market: Therapeutic Area Scope Key Takeaways

4.3   Revenue Growth Analysis, 2022 & 2028

4.4   Hormone Replacement Therapy

4.4.1           Hormone Replacement Therapy Market Estimates and Forecast, 2020-2028 (USD Million)

4.5   Pain Management

4.5.1           Pain Management Market Estimates and Forecast, 2020-2028 (USD Million)

4.6   Specialty Drugs

4.6.1           Specialty Drugs Market Estimates and Forecast, 2020-2028 (USD Million)

4.7   Dermatology

4.7.1           Dermatology Market Estimates and Forecast, 2020-2028 (USD Million)

4.8   Nutritional Supplements

4.8.1           Nutritional Supplements Market Estimates and Forecast, 2020-2028 (USD Million)

4.9  Others

4.9.1           Others Market Estimates and Forecast, 2020-2028 (USD Million)

5          GLOBAL COMPOUNDING PHARMACIES MARKET, BY AGE COHORT

5.1   Introduction

5.2   Compounding Pharmacies Market: Age Cohort Scope Key Takeaways

5.3   Revenue Growth Analysis, 2022 & 2028

5.4   Pediatric

5.4.1           Pediatric Market Estimates and Forecast, 2020-2028 (USD Million)

5.5   Adult

5.5.1           Adult Market Estimates and Forecast, 2020-2028 (USD Million)

5.6   Geriatric

5.6.1           Geriatric Market Estimates and Forecast, 2020-2028 (USD Million)

6         GLOBAL COMPOUNDING PHARMACIES MARKET, BY COMPOUNDING TYPE

6.1   Introduction

6.2   Compounding Pharmacies Market: Compounding Type Scope Key Takeaways

6.3   Revenue Growth Analysis, 2022 & 2028

6.4   Pharmaceutical Ingredient Alteration (PIA)

6.4.1           Pharmaceutical Ingredient Alteration (PIA) Market Estimates and Forecast, 2020-2028 (USD Million)

6.5   Currently Unavailable Pharmaceutical Manufacturing (CUPM)

6.5.1           Currently Unavailable Pharmaceutical Manufacturing (CUPM) Market Estimates and Forecast, 2020-2028 (USD Million)

6.6   Pharmaceutical Dosage Alteration (PDA)

6.6.1           Pharmaceutical Dosage Alteration (PDA) Market Estimates and Forecast, 2020-2028 (USD Million)

6.7   Others

6.7.1           Others Market Estimates and Forecast, 2020-2028 (USD Million)

7         GLOBAL COMPOUNDING PHARMACIES MARKET, BY STERILITY

7.1   Introduction

7.2   Compounding Pharmacies Market: Sterility Scope Key Takeaways

7.3   Revenue Growth Analysis, 2022 & 2028

7.4   Sterile

7.4.1           Sterile Market Estimates and Forecast, 2020-2028 (USD Million)

7.5   Non-sterile

7.5.1           Non-sterile Market Estimates and Forecast, 2020-2028 (USD Million)

8          GLOBAL COMPOUNDING PHARMACIES MARKET, BY REGION

8.1   Introduction

8.2   North America Compounding Pharmacies Market Estimates and Forecast, 2020-2028 (USD Million)

8.2.1        By Therapeutic Area

8.2.2        By Age Cohort

8.2.3        By Compounding Type

8.2.4        By Sterility  

8.2.5        By Country

8.2.5.1     U.S. Compounding Pharmacies Market Estimates and Forecast, 2020-2028 (USD Million)

8.2.5.1.1        By Therapeutic Area

8.2.5.1.2        By Age Cohort

8.2.5.1.3        By Compounding Type

8.2.5.1.4        By Sterility

8.2.5.2     Canada Compounding Pharmacies Market Estimates and Forecast, 2020-2028 (USD Million)

8.2.5.2.1        By Therapeutic Area

8.2.5.2.2        By Age Cohort

8.2.5.2.3        By Compounding Type

8.2.5.2.4        By Sterility

8.2.5.3     Mexico Compounding Pharmacies Market Estimates and Forecast, 2020-2028 (USD Million)

8.2.5.3.1        By Therapeutic Area

8.2.5.3.2        By Age Cohort

8.2.5.3.3        By Compounding Type

8.2.5.3.4        By Sterility

8.3   Europe Compounding Pharmacies Market Estimates and Forecast, 2020-2028 (USD Million)

8.3.1        By Therapeutic Area

8.3.2        By Age Cohort

8.3.3        By Compounding Type

8.3.4        By Sterility  

8.3.5        By Country

8.3.5.1     Germany Compounding Pharmacies Market Estimates and Forecast, 2020-2028 (USD Million)

8.3.5.1.1        By Therapeutic Area

8.3.5.1.2        By Age Cohort

8.3.5.1.3        By Compounding Type

8.3.5.1.4        By Sterility

8.3.5.2     U.K. Compounding Pharmacies Market Estimates and Forecast, 2020-2028 (USD Million)

8.3.5.2.1        By Therapeutic Area

8.3.5.2.2        By Age Cohort

8.3.5.2.3        By Compounding Type

8.3.5.2.4        By Sterility

8.3.5.3     France Compounding Pharmacies Market Estimates and Forecast, 2020-2028 (USD Million)

8.3.5.3.1        By Therapeutic Area

8.3.5.3.2        By Age Cohort

8.3.5.3.3        By Compounding Type

8.3.5.3.4        By Sterility

8.3.5.4     Italy Compounding Pharmacies Market Estimates and Forecast, 2020-2028 (USD Million)

8.3.5.4.1        By Therapeutic Area

8.3.5.4.2        By Age Cohort

8.3.5.4.3        By Compounding Type

8.3.5.4.4        By Sterility

8.3.5.5     Spain Compounding Pharmacies Market Estimates and Forecast, 2020-2028 (USD Million)

8.3.5.5.1        By Therapeutic Area

8.3.5.5.2        By Age Cohort

8.3.5.5.3        By Compounding Type

8.3.5.5.4        By Sterility

8.3.5.6     Netherlands Compounding Pharmacies Market Estimates and Forecast, 2020-2028 (USD Million)

8.3.5.6.1        By Therapeutic Area

8.3.5.6.2        By Age Cohort

8.3.5.6.3        By Compounding Type

8.3.5.6.4        By Sterility

8.3.5.7     Rest of Europe Compounding Pharmacies Market Estimates and Forecast, 2020-2028 (USD Million)

8.3.5.7.1        By Therapeutic Area

8.3.5.7.2        By Age Cohort

8.3.5.7.3        By Compounding Type

8.3.5.7.4        By Sterility

8.4   Asia Pacific Compounding Pharmacies Market Estimates and Forecast, 2020-2028 (USD Million)

8.4.1        By Therapeutic Area

8.4.2        By Age Cohort

8.4.3        By Compounding Type

8.4.4        By Sterility  

8.4.5        By Country

8.4.5.1     China Compounding Pharmacies Market Estimates and Forecast, 2020-2028 (USD Million)

8.4.5.1.1        By Therapeutic Area

8.4.5.1.2        By Age Cohort

8.4.5.1.3        By Compounding Type

8.4.5.1.4        By Sterility

8.4.5.2     Japan Compounding Pharmacies Market Estimates and Forecast, 2020-2028 (USD Million)

8.4.5.2.1        By Therapeutic Area

8.4.5.2.2        By Age Cohort

8.4.5.2.3        By Compounding Type

8.4.5.2.4        By Sterility

8.4.5.3     India Compounding Pharmacies Market Estimates and Forecast, 2020-2028 (USD Million)

8.4.5.3.1        By Therapeutic Area

8.4.5.3.2        By Age Cohort

8.4.5.3.3        By Compounding Type

8.4.5.3.4        By Sterility

8.4.5.4     South Korea Compounding Pharmacies Market Estimates and Forecast, 2020-2028 (USD Million)

8.4.5.4.1        By Therapeutic Area

8.4.5.4.2        By Age Cohort

8.4.5.4.3        By Compounding Type

8.4.5.4.4        By Sterility

8.4.5.5     Singapore Compounding Pharmacies Market Estimates and Forecast, 2020-2028 (USD Million)

8.4.5.5.1        By Therapeutic Area

8.4.5.5.2        By Age Cohort

8.4.5.5.3        By Compounding Type

8.4.5.5.4        By Sterility

8.4.5.6     Malaysia Compounding Pharmacies Market Estimates and Forecast, 2020-2028 (USD Million)

8.4.5.6.1        By Therapeutic Area

8.4.5.6.2        By Age Cohort

8.4.5.6.3        By Compounding Type

8.4.5.6.4        By Sterility

8.4.5.7     Thailand Compounding Pharmacies Market Estimates and Forecast, 2020-2028 (USD Million)

8.4.5.7.1        By Therapeutic Area

8.4.5.7.2        By Age Cohort

8.4.5.7.3        By Compounding Type

8.4.5.7.4        By Sterility

8.4.5.8     Indonesia Compounding Pharmacies Market Estimates and Forecast, 2020-2028 (USD Million)

8.4.5.8.1        By Therapeutic Area

8.4.5.8.2        By Age Cohort

8.4.5.8.3        By Compounding Type

8.4.5.8.4        By Sterility

8.4.5.9     Vietnam Compounding Pharmacies Market Estimates and Forecast, 2020-2028 (USD Million)

8.4.5.9.1        By Therapeutic Area

8.4.5.9.2        By Age Cohort

8.4.5.9.3        By Compounding Type

8.4.5.9.4        By Sterility

8.4.5.10  Taiwan Compounding Pharmacies Market Estimates and Forecast, 2020-2028 (USD Million)

8.4.5.10.1      By Therapeutic Area

8.4.5.10.2      By Age Cohort

8.4.5.10.3      By Compounding Type

8.4.5.10.4      By Sterility

8.4.5.11  Rest of Asia Pacific Compounding Pharmacies Market Estimates and Forecast, 2020-2028 (USD Million)

8.4.5.11.1      By Therapeutic Area

8.4.5.11.2      By Age Cohort

8.4.5.11.3      By Compounding Type

8.4.5.11.4      By Sterility

8.5   Middle East and Africa Compounding Pharmacies Market Estimates and Forecast, 2020-2028 (USD Million)

8.5.1        By Therapeutic Area

8.5.2        By Age Cohort

8.5.3        By Compounding Type

8.5.4        By Sterility  

8.5.5        By Country

8.5.5.1     Saudi Arabia Compounding Pharmacies Market Estimates and Forecast, 2020-2028 (USD Million)

8.5.5.1.1        By Therapeutic Area

8.5.5.1.2        By Age Cohort

8.5.5.1.3        By Compounding Type

8.5.5.1.4        By Sterility

8.5.5.2     U.A.E. Compounding Pharmacies Market Estimates and Forecast, 2020-2028 (USD Million)

8.5.5.2.1        By Therapeutic Area

8.5.5.2.2        By Age Cohort

8.5.5.2.3        By Compounding Type

8.5.5.2.4        By Sterility

8.5.5.3     Israel Compounding Pharmacies Market Estimates and Forecast, 2020-2028 (USD Million)

8.5.4.3.1        By Therapeutic Area

8.5.4.3.2        By Age Cohort

8.5.4.3.3        By Compounding Type

8.5.5.3.4        By Sterility

8.5.5.4     South Africa Compounding Pharmacies Market Estimates and Forecast, 2020-2028 (USD Million)

8.5.5.4.1        By Therapeutic Area

8.5.5.4.2        By Age Cohort

8.5.5.4.3        By Compounding Type

8.5.5.4.4        By Sterility

8.5.5.5     Rest of Middle East and Africa Compounding Pharmacies Market Estimates and Forecast, 2020-2028 (USD Million)

8.5.5.5.1        By Therapeutic Area

8.5.5.5.2        By Age Cohort

8.5.5.5.2        By Compounding Type

8.5.5.5.4        By Sterility

8.6   Central and South America Compounding Pharmacies Market Estimates and Forecast, 2020-2028 (USD Million)

8.6.1        By Therapeutic Area

8.6.2        By Age Cohort

8.6.3        By Compounding Type

8.6.4        By Sterility

8.6.5        By Country

8.6.5.1     Brazil Compounding Pharmacies Market Estimates and Forecast, 2020-2028 (USD Million)

8.6.5.1.1        By Therapeutic Area

8.6.5.1.2        By Age Cohort

8.6.5.1.3        By Compounding Type

8.6.5.1.4        By Sterility

8.6.5.2     Argentina Compounding Pharmacies Market Estimates and Forecast, 2020-2028 (USD Million)

8.6.5.2.1        By Therapeutic Area

8.6.5.2.2        By Age Cohort

8.6.5.2.3        By Compounding Type

8.6.5.2.4        By Sterility

8.6.5.3     Chile Compounding Pharmacies Market Estimates and Forecast, 2020-2028 (USD Million)

8.6.5.3.1        By Therapeutic Area

8.6.5.3.2        By Age Cohort

8.6.5.3.3        By Compounding Type

8.6.5.5.4        By Sterility

8.6.5.4     Rest of Central and South America Compounding Pharmacies Market Estimates and Forecast, 2020-2028 (USD Million)

8.6.5.4.1        By Therapeutic Area

8.6.5.4.2        By Age Cohort

8.6.5.4.3        By Compounding Type

8.6.5.4.4        By Sterility

9          COMPETITIVE LANDCAPE

9.1   Company Market Share Analysis

9.2   Four Quadrant Positioning Matrix

9.2.1        Market Leaders

9.2.2        Market Visionaries

9.2.3        Market Challengers

9.2.4        Niche Market Players

9.3   Vendor Landscape

9.3.1        North America

9.3.2        Europe

9.3.3        Asia Pacific

9.3.4        Rest of the World

9.4   Company Profiles  

9.4.1        JL Diekman and AQ Touchard

9.4.1.1 Business Description & Financial Analysis

9.4.1.2 SWOT Analysis

9.4.1.3 Products & Services Offered

9.4.1.4 Strategic Alliances between Business Partners

9.4.2        Walgreen Co.

9.4.2.1 Business Description & Financial Analysis

9.4.2.2 SWOT Analysis

9.4.2.3 Products & Services Offered

9.4.2.4 Strategic Alliances between Business Partners

9.4.3        Fagron

9.4.3.1 Business Description & Financial Analysis

9.4.3.2 SWOT Analysis

9.4.3.3 Products & Services Offered

9.4.3.4 Strategic Alliances between Business Partners

9.4.4        Albertsons Companies

9.4.4.1 Business Description & Financial Analysis

9.4.4.2 SWOT Analysis

9.4.4.3 Products & Services Offered

9.4.4.4 Strategic Alliances between Business Partners

9.4.5        The London Specialist Pharmacy Ltd

9.4.5.1 Business Description & Financial Analysis

9.4.5.2 SWOT Analysis

9.4.5.3 Products & Services Offered

9.4.5.4 Strategic Alliances between Business Partners

9.4.6        Formul8

9.4.6.1 Business Description & Financial Analysis

9.4.6.2 SWOT Analysis

9.4.6.3 Products & Services Offered

9.4.6.4 Strategic Alliances between Business Partners

9.4.7        Galenic Laboratories Limited  

9.4.7.1 Business Description & Financial Analysis

9.4.7.2 SWOT Analysis

9.4.7.3 Products & Services Offered

9.4.8.4 Strategic Alliances between Business Partners

9.4.8        Aurora Compounding

9.4.8.1 Business Description & Financial Analysis

9.4.8.2 SWOT Analysis

9.4.8.3 Products & Services Offered

9.4.8.4 Strategic Alliances between Business Partners

9.4.9        MEDS Pharmacy

9.4.9.1 Business Description & Financial Analysis

9.4.9.2 SWOT Analysis

9.4.9.3 Products & Services Offered

9.4.9.4 Strategic Alliances between Business Partners

9.4.10       Apollo Clinical Pharmacy

9.4.10.1 Business Description & Financial Analysis

9.4.10.2 SWOT Analysis

9.4.10.3 Products & Services Offered

9.4.10.4 Strategic Alliances between Business Partners

9.4.11      Other Companies

9.4.11.1 Business Description & Financial Analysis

9.4.11.2 SWOT Analysis

9.4.11.3 Products & Services Offered

9.4.11.4 Strategic Alliances between Business Partners

10        RESEARCH METHODOLOGY

10.1 Market Introduction

10.1.1      Market Definition

10.1.2        Market Scope & Segmentation

10.2 Information Procurement

10.2.1      Secondary Research

10.2.1.1           Purchased Databases

10.2.1.2           GMEs Internal Data Repository

10.2.1.3           Secondary Resources & Third Party Perspectives

10.2.1.4           Company Information Sources

10.2.2      Primary Research

10.2.2.1           Various Types of Respondents for Primary Interviews

10.2.2.2           Number of Interviews Conducted throughout the Research Process

10.2.2.3           Primary Stakeholders

10.2.2.4           Discussion Guide for Primary Participants

10.2.3      Expert Panels

10.2.3.1           Expert Panels Across 30+ Industry

10.2.4      Paid Local Experts

10.2.4.1           Paid Local Experts Across 30+ Industry Across each Region

10.3 Market Estimation

10.3.1      Top-Down Approach

10.3.1.1           Macro-Economic Indicators Considered

10.3.1.2           Micro-Economic Indicators Considered

10.3.2      Bottom Up Approach

10.3.2.1           Company Share Analysis Approach

10.3.2.2           Estimation of Potential Product Sales

10.4 Data Triangulation

10.4.1      Data Collection

10.4.2        Time Series, Cross Sectional & Panel Data Analysis

10.4.3      Cluster Analysis

10.5 Analysis and Output

10.5.1        Inhouse AI Based Real Time Analytics Tool

10.5.2        Output From Desk & Primary Research

10.6 Research Assumptions & Limitations

10.7.1      Research Assumptions

10.7.2      Research Limitations

LIST OF TABLES

1 Global Compounding Pharmacies Market, By Therapeutic Area, 2020-2028 (USD Mllion)

2 Hormone Replacement Therapy Market, By Region, 2020-2028 (USD Mllion)         

3 Pain Management Market, By Region, 2020-2028 (USD Mllion)        

4 Specialty Drugs Market, By Region, 2020-2028 (USD Mllion)           

5 Dermatology Market, By Region, 2020-2028 (USD Mllion)

6 Nutritional Supplements Market, By Region, 2020-2028 (USD Mllion)

7 Others Market, By Region, 2020-2028 (USD Mllion)

8 Global Compounding Pharmacies Market, By Age Cohort, 2020-2028 (USD Mllion)

9 Pediatric Market, By Region, 2020-2028 (USD Mllion)          

10 Adult Market, By Region, 2020-2028 (USD Mllion)

11 Geriatric Market, By Region, 2020-2028 (USD Mllion)

12 Global Compounding Pharmacies Market, By Compounding Type, 2020-2028 (USD Mllion)

13 Pharmaceutical Ingredient Alteration (PIA) Market, By Region, 2020-2028 (USD Mllion)              

14 Currently Unavailable Pharmaceutical Manufacturing (CUPM) Market, By Region, 2020-2028 (USD Mllion)      

15 Pharmaceutical Dosage Alteration (PDA) Market, By Region, 2020-2028 (USD Mllion)    

16 Others Market, By Region, 2020-2028 (USD Mllion)

17 Global Compounding Pharmacies Market, By Sterility, 2020-2028 (USD Mllion)

18 Sterile Market, By Region, 2020-2028 (USD Mllion)

19 Non-sterile Market, By Region, 2020-2028 (USD Mllion)     

20 Regional Analysis, 2020-2028 (USD Mllion)

21 North America Compounding Pharmacies Market, By Therapeutic Area, 2020-2028 (USD Million)

22 North America Compounding Pharmacies Market, By Age Cohort, 2020-2028 (USD Million)

23 North America Compounding Pharmacies Market, By Compounding Type, 2020-2028 (USD Million)

24 North America Compounding Pharmacies Market, By Sterility, 2020-2028 (USD Million)

25 North America Compounding Pharmacies Market, By Country, 2020-2028 (USD Million)

26 U.S Compounding Pharmacies Market, By Therapeutic Area, 2020-2028 (USD Million)

27 U.S Compounding Pharmacies Market, By Age Cohort, 2020-2028 (USD Million)

28 U.S Compounding Pharmacies Market, By Compounding Type, 2020-2028 (USD Million)

29 U.S Compounding Pharmacies Market, By Sterility, 2020-2028 (USD Million)

30 Canada Compounding Pharmacies Market, By Therapeutic Area, 2020-2028 (USD Million)

31 Canada Compounding Pharmacies Market, By Age Cohort, 2020-2028 (USD Million)

32 Canada Compounding Pharmacies Market, By Compounding Type, 2020-2028 (USD Million)

33 CANADA Compounding Pharmacies Market, By Sterility, 2020-2028 (USD Million)

34 Mexico Compounding Pharmacies Market, By Therapeutic Area, 2020-2028 (USD Million)

35 Mexico Compounding Pharmacies Market, By Age Cohort, 2020-2028 (USD Million)

36 Mexico Compounding Pharmacies Market, By Compounding Type, 2020-2028 (USD Million)

37 mexico Compounding Pharmacies Market, By Sterility, 2020-2028 (USD Million)

38 Europe Compounding Pharmacies Market, By Therapeutic Area, 2020-2028 (USD Million)

39 Europe Compounding Pharmacies Market, By Age Cohort, 2020-2028 (USD Million)

40 Europe Compounding Pharmacies Market, By Compounding Type, 2020-2028 (USD Million)

41 europe Compounding Pharmacies Market, By Sterility, 2020-2028 (USD Million)

42 europe Compounding Pharmacies Market, By country, 2020-2028 (USD Million)

43 Germany Compounding Pharmacies Market, By Therapeutic Area, 2020-2028 (USD Million)

44 Germany Compounding Pharmacies Market, By Age Cohort, 2020-2028 (USD Million)

45 Germany Compounding Pharmacies Market, By Compounding Type, 2020-2028 (USD Million)

46 germany Compounding Pharmacies Market, By Sterility, 2020-2028 (USD Million)

47 U.K Compounding Pharmacies Market, By Therapeutic Area, 2020-2028 (USD Million)

48 U.K Compounding Pharmacies Market, By Age Cohort, 2020-2028 (USD Million)

49 U.K Compounding Pharmacies Market, By Compounding Type, 2020-2028 (USD Million)

50 U.k Compounding Pharmacies Market, By Sterility, 2020-2028 (USD Million)

51 France Compounding Pharmacies Market, By Therapeutic Area, 2020-2028 (USD Million)

52 France Compounding Pharmacies Market, By Age Cohort, 2020-2028 (USD Million)

53 France Compounding Pharmacies Market, By Compounding Type, 2020-2028 (USD Million)

54 france Compounding Pharmacies Market, By Sterility, 2020-2028 (USD Million)

55 Italy Compounding Pharmacies Market, By Therapeutic Area, 2020-2028 (USD Million)

56 Italy Compounding Pharmacies Market, By Age Cohort, 2020-2028 (USD Million)

57 Italy Compounding Pharmacies Market, By Compounding Type, 2020-2028 (USD Million)

58 italy Compounding Pharmacies Market, By Sterility, 2020-2028 (USD Million)

59 Spain Compounding Pharmacies Market, By Therapeutic Area, 2020-2028 (USD Million)

60 Spain Compounding Pharmacies Market, By Age Cohort, 2020-2028 (USD Million)

61 Spain Compounding Pharmacies Market, By Compounding Type, 2020-2028 (USD Million)

62 spain Compounding Pharmacies Market, By Sterility, 2020-2028 (USD Million)

63 Rest Of Europe Compounding Pharmacies Market, By Therapeutic Area, 2020-2028 (USD Million)

64 Rest Of Europe Compounding Pharmacies Market, By Age Cohort, 2020-2028 (USD Million)

65 Rest of Europe Compounding Pharmacies Market, By Compounding Type, 2020-2028 (USD Million)

66 REST OF EUROPE Compounding Pharmacies Market, By Sterility, 2020-2028 (USD Million)

67 Asia Pacific Compounding Pharmacies Market, By Therapeutic Area, 2020-2028 (USD Million)

68 Asia Pacific Compounding Pharmacies Market, By Age Cohort, 2020-2028 (USD Million)

69 Asia Pacific Compounding Pharmacies Market, By Compounding Type, 2020-2028 (USD Million)

70 asia Compounding Pharmacies Market, By Sterility, 2020-2028 (USD Million)

71 Asia Pacific Compounding Pharmacies Market, By Country, 2020-2028 (USD Million)

72 China Compounding Pharmacies Market, By Therapeutic Area, 2020-2028 (USD Million)

73 China Compounding Pharmacies Market, By Age Cohort, 2020-2028 (USD Million)

74 China Compounding Pharmacies Market, By Compounding Type, 2020-2028 (USD Million)

75 china Compounding Pharmacies Market, By Sterility, 2020-2028 (USD Million)

76 India Compounding Pharmacies Market, By Therapeutic Area, 2020-2028 (USD Million)

77 India Compounding Pharmacies Market, By Age Cohort, 2020-2028 (USD Million)

78 India Compounding Pharmacies Market, By Compounding Type, 2020-2028 (USD Million)

79 india Compounding Pharmacies Market, By Sterility, 2020-2028 (USD Million)

80 Japan Compounding Pharmacies Market, By Therapeutic Area, 2020-2028 (USD Million)

81 Japan Compounding Pharmacies Market, By Age Cohort, 2020-2028 (USD Million)

82 Japan Compounding Pharmacies Market, By Compounding Type, 2020-2028 (USD Million)

83 japan Compounding Pharmacies Market, By Sterility, 2020-2028 (USD Million)

84 South Korea Compounding Pharmacies Market, By Therapeutic Area, 2020-2028 (USD Million)

85 South Korea Compounding Pharmacies Market, By Age Cohort, 2020-2028 (USD Million)

86 South Korea Compounding Pharmacies Market, By Compounding Type, 2020-2028 (USD Million)

87 south korea Compounding Pharmacies Market, By Sterility, 2020-2028 (USD Million)

88 Singapore Compounding Pharmacies Market, By Therapeutic Area, 2020-2028 (USD Million)

89 Singapore Compounding Pharmacies Market, By Age Cohort, 2020-2028 (USD Million)

90 Singapore Compounding Pharmacies Market, By Compounding Type, 2020-2028 (USD Million)

91 Singapore Compounding Pharmacies Market, By Sterility, 2020-2028 (USD Million

92 Malaysia Compounding Pharmacies Market, By Therapeutic Area, 2020-2028 (USD Million)

93 Malaysia Compounding Pharmacies Market, By Age Cohort, 2020-2028 (USD Million)

94 Malaysia Compounding Pharmacies Market, By Compounding Type, 2020-2028 (USD Million)

95 Malaysia Compounding Pharmacies Market, By Sterility, 2020-2028 (USD Million

96 Thailand Compounding Pharmacies Market, By Therapeutic Area, 2020-2028 (USD Million)

97 Thailand Compounding Pharmacies Market, By Age Cohort, 2020-2028 (USD Million)

98 Thailand Compounding Pharmacies Market, By Compounding Type, 2020-2028 (USD Million)

99 Thailand Compounding Pharmacies Market, By Sterility, 2020-2028 (USD Million

100 Indonesia Compounding Pharmacies Market, By Therapeutic Area, 2020-2028 (USD Million)

101 Indonesia Compounding Pharmacies Market, By Age Cohort, 2020-2028 (USD Million)

102 Indonesia Compounding Pharmacies Market, By Compounding Type, 2020-2028 (USD Million)

103 Indonesia Compounding Pharmacies Market, By Sterility, 2020-2028 (USD Million

104 Vietnam Compounding Pharmacies Market, By Therapeutic Area, 2020-2028 (USD Million)

105 Vietnam Compounding Pharmacies Market, By Age Cohort, 2020-2028 (USD Million)

106 Vietnam Compounding Pharmacies Market, By Compounding Type, 2020-2028 (USD Million)

107 Vietnam Compounding Pharmacies Market, By Sterility, 2020-2028 (USD Million

108 Taiwan Compounding Pharmacies Market, By Therapeutic Area, 2020-2028 (USD Million)

109 Taiwan Compounding Pharmacies Market, By Age Cohort, 2020-2028 (USD Million)

110 Taiwan Compounding Pharmacies Market, By Compounding Type, 2020-2028 (USD Million)

111 Taiwan Compounding Pharmacies Market, By Sterility, 2020-2028 (USD Million

112 Rest of Asia Pacific Compounding Pharmacies Market, By Therapeutic Area, 2020-2028 (USD Million)

113 Rest of Asia Pacific Compounding Pharmacies Market, By Age Cohort, 2020-2028 (USD Million)

114 Rest of Asia Pacific Compounding Pharmacies Market, By Compounding Type, 2020-2028 (USD Million)

115 Rest of Asia Pacific Compounding Pharmacies Market, By Sterility, 2020-2028 (USD Million

116 Middle East and Africa Compounding Pharmacies Market, By Therapeutic Area, 2020-2028 (USD Million)

117 Middle East and Africa Compounding Pharmacies Market, By Age Cohort, 2020-2028 (USD Million)

118 Middle East and Africa Compounding Pharmacies Market, By Compounding Type, 2020-2028 (USD Million)

119 MIDDLE EAST and AFRICA Compounding Pharmacies Market, By Sterility, 2020-2028 (USD Million)

120 Middle East and Africa Compounding Pharmacies Market, By Country, 2020-2028 (USD Million)

121 Saudi Arabia Compounding Pharmacies Market, By Therapeutic Area, 2020-2028 (USD Million)

122 Saudi Arabia Compounding Pharmacies Market, By Age Cohort, 2020-2028 (USD Million)

123 Saudi Arabia Compounding Pharmacies Market, By Compounding Type, 2020-2028 (USD Million)

124 saudi arabia Compounding Pharmacies Market, By Sterility, 2020-2028 (USD Million)

125 UAE Compounding Pharmacies Market, By Therapeutic Area, 2020-2028 (USD Million)

126 UAE Compounding Pharmacies Market, By Age Cohort, 2020-2028 (USD Million)

127 UAE Compounding Pharmacies Market, By Compounding Type, 2020-2028 (USD Million)

128 uae Compounding Pharmacies Market, By Sterility, 2020-2028 (USD Million)

129 Israel Compounding Pharmacies Market, By Therapeutic Area, 2020-2028 (USD Million)

130 Israel Compounding Pharmacies Market, By Age Cohort, 2020-2028 (USD Million)

131 Israel Compounding Pharmacies Market, By Compounding Type, 2020-2028 (USD Million)

132 Israel Compounding Pharmacies Market, By Sterility, 2020-2028 (USD Million)

133 South Africa Compounding Pharmacies Market, By Therapeutic Area, 2020-2028 (USD Million)

134 South Africa Compounding Pharmacies Market, By Age Cohort, 2020-2028 (USD Million)

135 South Africa Compounding Pharmacies Market, By Compounding Type, 2020-2028 (USD Million)

136 South Africa Compounding Pharmacies Market, By Sterility, 2020-2028 (USD Million)

137 Rest of Middle East and Africa Compounding Pharmacies Market, By Therapeutic Area, 2020-2028 (USD Million)

138 Rest of Middle East and Africa Compounding Pharmacies Market, By Age Cohort, 2020-2028 (USD Million)

139 Rest of Middle East and Africa Compounding Pharmacies Market, By Compounding Type, 2020-2028 (USD Million)

140 Rest of Middle East and Africa Compounding Pharmacies Market, By Sterility, 2020-2028 (USD Million)

141 Central and South America Compounding Pharmacies Market, By Therapeutic Area, 2020-2028 (USD Million)

142 Central and South America Compounding Pharmacies Market, By Age Cohort, 2020-2028 (USD Million)

143 Central and  South America Compounding Pharmacies Market, By Compounding Type, 2020-2028 (USD Million)

144 CENTRAL and SOUTH AMERICA Compounding Pharmacies Market, By Sterility, 2020-2028 (USD Million)

145 Central and South America Compounding Pharmacies Market, By Country, 2020-2028 (USD Million)

146 Brazil Compounding Pharmacies Market, By Therapeutic Area, 2020-2028 (USD Million)

147 Brazil Compounding Pharmacies Market, By Age Cohort, 2020-2028 (USD Million)

148 Brazil Compounding Pharmacies Market, By Compounding Type, 2020-2028 (USD Million)

149 brazil Compounding Pharmacies Market, By Sterility, 2020-2028 (USD Million)

150 Argentina Compounding Pharmacies Market, By Therapeutic Area, 2020-2028 (USD Million)

151 Argentina Compounding Pharmacies Market, By Age Cohort, 2020-2028 (USD Million)

152 Argentina Compounding Pharmacies Market, By Compounding Type, 2020-2028 (USD Million)

153  Argentina Compounding Pharmacies Market, By Sterility, 2020-2028 (USD Million)

154 Chile Compounding Pharmacies Market, By Therapeutic Area, 2020-2028 (USD Million)

155 Chile Compounding Pharmacies Market, By Age Cohort, 2020-2028 (USD Million)

156 Chile Compounding Pharmacies Market, By Compounding Type, 2020-2028 (USD Million)

157 Chile Compounding Pharmacies Market, By Sterility, 2020-2028 (USD Million)

158 Rest of Central and South America Compounding Pharmacies Market, By Therapeutic Area, 2020-2028 (USD Million)

159 Rest of Central and South America Compounding Pharmacies Market, By Age Cohort, 2020-2028 (USD Million)

160 Rest of Central and South America Compounding Pharmacies Market, By Compounding Type, 2020-2028 (USD Million)

161 Rest of Central and South America Compounding Pharmacies Market, By Sterility, 2020-2028 (USD Million)

162 JL Diekman and AQ Touchard: Products & Services Offering

163 Walgreen Co.: Products & Services Offering          

164 Fagron: Products & Services Offering        

165 Albertsons Companies: Products & Services Offering     

166 The London Specialist Pharmacy Ltd: Products & Services Offering        

167 FORMUL8: Products & Services Offering     

168 Galenic Laboratories Limited : Products & Services Offering      

169 Aurora Compounding: Products & Services Offering       

170 MEDS Pharmacy, Inc: Products & Services Offering            

171  Apollo Clinical Pharmacy: Products & Services Offering             

172 Other Companies: Products & Services Offering  

LIST OF FIGURES

1 Global Compounding Pharmacies Market Overview

2 Global Compounding Pharmacies Market Value From 2020-2028 (USD Mllion)

3 Global Compounding Pharmacies Market Share, By Therapeutic Area (2022)

4 Global Compounding Pharmacies Market Share, By Age Cohort (2022)

5 Global Compounding Pharmacies Market Share, By Compounding Type (2022)

6 Global Compounding Pharmacies Market Share, By Sterility (2022)

7 Global Compounding Pharmacies Market, By Region (Asia Pacific Market)

8 Technological Trends In Global Compounding Pharmacies Market

9 Four Quadrant Competitor Positioning Matrix

10 Impact Of Macro & Micro Indicators On The Market

11 Impact Of Key Drivers On The Global Compounding Pharmacies Market

12 Impact Of Challenges On The Global Compounding Pharmacies Market

13 Porter’s Five Forces Analysis

14 Global Compounding Pharmacies Market: By Therapeutic Area Scope Key Takeaways

15 Global Compounding Pharmacies Market, By Therapeutic Area Segment: Revenue Growth Analysis

16 Hormone Replacement Therapy Market, By Region, 2020-2028 (USD Mllion)       

17 Pain Management Market, By Region, 2020-2028 (USD Mllion)

18 Specialty Drugs Market, By Region, 2020-2028 (USD Mllion)

19 Dermatology Market, By Region, 2020-2028 (USD Mllion)     

20 Nutritional Supplements Market, By Region, 2020-2028 (USD Mllion)

21 Others Market, By Region, 2020-2028 (USD Mllion)

22 Global Compounding Pharmacies Market: By Age Cohort Scope Key Takeaways

23 Global Compounding Pharmacies Market, By Age Cohort Segment: Revenue Growth Analysis

24 Pediatric Market, By Region, 2020-2028 (USD Mllion)

25 Adult Market, By Region, 2020-2028 (USD Mllion)

26 Geriatric Market, By Region, 2020-2028 (USD Mllion)

27 Global Compounding Pharmacies Market: By Compounding Type Scope Key Takeaways

28 Global Compounding Pharmacies Market, By Compounding Type Segment: Revenue Growth Analysis

29 Pharmaceutical Ingredient Alteration (PIA) Market, By Region, 2020-2028 (USD Mllion)

30 Currently Unavailable Pharmaceutical Manufacturing (CUPM) Market, By Region, 2020-2028 (USD Mllion)

31 Pharmaceutical Dosage Alteration (PDA) Market, By Region, 2020-2028 (USD Mllion)

32 Others Market, By Region, 2020-2028 (USD Mllion)    

33 Global Compounding Pharmacies Market: By Sterility Scope Key Takeaways

34 Global Compounding Pharmacies Market, By Sterility Segment: Revenue Growth Analysis

35 Sterile Market, By Region, 2020-2028 (USD Mllion)    

36 Non-sterile Market, By Region, 2020-2028 (USD Mllion)

37 Regional Segment: Revenue Growth Analysis

38 Global Compounding Pharmacies Market: Regional Analysis

39 North America Compounding Pharmacies Market Overview

40 North America Compounding Pharmacies Market, By Therapeutic Area

41 North America Compounding Pharmacies Market, By Age Cohort

42 North America Compounding Pharmacies Market, By Compounding Type

43 North America Compounding Pharmacies Market, By Sterility

44 North America Compounding Pharmacies Market, By Country

45 U.S. Compounding Pharmacies Market, By Therapeutic Area

46 U.S. Compounding Pharmacies Market, By Age Cohort

47 U.S. Compounding Pharmacies Market, By Compounding Type

48 U.S. Compounding Pharmacies Market, By Sterility

49 Canada Compounding Pharmacies Market, By Therapeutic Area

50 Canada Compounding Pharmacies Market, By Age Cohort

51 Canada Compounding Pharmacies Market, By Compounding Type

52 Canada Compounding Pharmacies Market, By Sterility

53 Mexico Compounding Pharmacies Market, By Therapeutic Area

54 Mexico Compounding Pharmacies Market, By Age Cohort

55 Mexico Compounding Pharmacies Market, By Compounding Type

56 Mexico Compounding Pharmacies Market, By Sterility

57 Four Quadrant Positioning Matrix

58 Company Market Share Analysis

59 JL Diekman and AQ Touchard: Company Snapshot

60 JL Diekman and AQ Touchard: SWOT Analysis

61 JL Diekman and AQ Touchard: Geographic Presence

62 Walgreen Co.: Company Snapshot

63 Walgreen Co.: SWOT Analysis

64 Walgreen Co.: Geographic Presence

65 Fagron: Company Snapshot

66 Fagron: SWOT Analysis

67 Fagron: Geographic Presence

68 Albertsons Companies: Company Snapshot

69 Albertsons Companies: Swot Analysis

70 Albertsons Companies: Geographic Presence

71 The London Specialist Pharmacy Ltd: Company Snapshot

72 The London Specialist Pharmacy Ltd: SWOT Analysis

73 The London Specialist Pharmacy Ltd: Geographic Presence

74 Formul8: Company Snapshot

75 Formul8: SWOT Analysis

76 Formul8: Geographic Presence

77 Galenic Laboratories Limited : Company Snapshot

78 Galenic Laboratories Limited : SWOT Analysis

79 Galenic Laboratories Limited : Geographic Presence

80 Aurora Compounding: Company Snapshot

81 Aurora Compounding: SWOT Analysis

82 Aurora Compounding: Geographic Presence

83 MEDS Pharmacy, Inc.: Company Snapshot

84 MEDS Pharmacy, Inc.: SWOT Analysis

85 MEDS Pharmacy, Inc.: Geographic Presence

86  Apollo Clinical Pharmacy: Company Snapshot

87  Apollo Clinical Pharmacy: SWOT Analysis

88  Apollo Clinical Pharmacy: Geographic Presence

89 Other Companies: Company Snapshot

90 Other Companies: SWOT Analysis

91 Other Companies: Geographic Presence

The Global Compounding Pharmacies Market has been studied from the year 2019 till 2028. However, the CAGR provided in the report is from the year 2023 to 2028. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

Compounding Pharmacies Market Size

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Compounding Pharmacies Market.

Compounding Pharmacies Market Growth

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Compounding Pharmacies Market Trends

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

Compounding Pharmacies Market Share

We value your investment and offer free customization with every report to fulfil your exact research needs.
This website is secure and your personal details are safe. Privacy
You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The global compounding pharmacies market is projected to grow at a CAGR of 6% from 2023 to 2028.
Walgreen Co., JL Diekman and AQ Touchard, Fagron, Albertsons Companies, The London Specialist Pharmacy Ltd, Galenic Laboratories Limited, Aurora Compounding, MEDS Pharmacy, Apollo Clinical Pharmacy, and Formul8, among others, are some of the key players operating in the global compounding pharmacies market.
Opportunities in the global compounding pharmacies market include increasing demand for personalized medications, especially among aging populations. Expansion into underserved regions, adoption of advanced technologies to enhance compounding processes, and collaborations with healthcare providers can also open new avenues for growth. Additionally, addressing medication shortages and offering innovative formulations for various therapeutic needs present significant opportunities for compounding pharmacies.
The increasing demand for personalized medications, medication shortages, increasing aging populations with unique healthcare needs, growing awareness of personalized medicine, advancements in medical treatments, and regulatory guidelines ensuring the quality and safety of compounded drugs are the major factors propelling growth of the global compounding pharmacies market growth.

Tailor made solutions just for you

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

OUR CLIENTS

  • Client of Global Market Estimates - Fedex
  • Client of Global Market Estimates - Samsung
  • Client of Global Market Estimates - Siemens
  • Client of Global Market Estimates - Lonza
  • Client of Global Market Estimates - DuPont
  • Client of Global Market Estimates - Medtronic
  • Client of Global Market Estimates - Toray
  • Client of Global Market Estimates - Signify
  • Client of Global Market Estimates - Teledyne
  • Client of Global Market Estimates - Trelleborg
  • Client of Global Market Estimates - Kikkoman Biochemifa
  • Client of Global Market Estimates - Leoni
  • Client of Global Market Estimates - Molnlycke
  • Client of Global Market Estimates - Spirent
  • Client of Global Market Estimates - Tokyo Electron Limited
  • Client of Global Market Estimates - Aranca
  • Client of Global Market Estimates - Asahi Kasei
  • Client of Global Market Estimates - Chimai
  • Client of Global Market Estimates - Grapsud
  • Client of Global Market Estimates - Horiba
  • Client of Global Market Estimates - Indorama
  • Client of Global Market Estimates - L&T
  • Client of Global Market Estimates - Integralife
  • Client of Global Market Estimates - Synamedia
  • Client of Global Market Estimates - Sorrento Therapeutics
  • Client of Global Market Estimates - Solenis
  • Client of Global Market Estimates - Sartorius